Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis

Osteoporosis International

Volumn 23, Issue 3, 2012, Pages 1131-1140

  Nakamura, T ^a   Matsumoto, T ^b   Sugimoto, T ^c   Shiraki, M ^d  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d Research Institute and Practice for Involutional Diseases   (Japan)

Author keywords

AMG 162; BMD; Bone ALP; Serum CTX I; Urinary NTX I Cr

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; CREATININE; DENOSUMAB; PLACEBO; VITAMIN D;

ADULT; AGED; ARTICLE; BACKACHE; BONE DENSITY; BONE TURNOVER; CERVICAL SPINE FRACTURE; CERVICAL SPINE RADIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONTUSION; CREATININE URINE LEVEL; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; ECZEMA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPOCALCEMIA; JAPANESE; LUMBAR SPINE; PERIARTHRITIS; PHASE 2 CLINICAL TRIAL; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCREENING TEST; UPPER RESPIRATORY TRACT INFECTION;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HIP JOINT; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RADIUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857443087     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1786-8     Document Type: Article

References (12)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy 2001 Osteoporosis prevention, diagnosis, and therapy JAMA 285 785 795 10.1001/jama.285.6.785
2. JY Reginster N Burlet 2006 Osteoporosis: a still increasing prevalence Bone 38 2 suppl 1 S4 S9 16455317 10.1016/j.bone.2005.11.024 (Pubitemid 43190767)
3. T Sone M Fukunaga 2004 Prevalence of osteoporosis in Japan and the international comparison Nippon Rinsho 62 Suppl 2 197 200 15035124
4. GA Rodan TJ Martin 2000 Therapeutic approaches to bone diseases Science 289 1508 1514 10968781 10.1126/science.289.5484.1508 1:CAS:528: DC%2BD3cXmt1Kgsb4%3D
5. MR McClung EM Lewiecki SB Cohen MA Bolognese GC Woodson AH Moffett M Peacock PD Miller SN Lederman CH Chesnut D Lain AJ Kivitz DL Holloway C Zhang MC Peterson PJ Bekker AMG 162 Bone Loss Study Group 2006 Denosumab in postmenopausal women with low bone mineral density N Engl J Med 354 821 831 16495394 10.1056/NEJMoa044459 1:CAS:528:DC%2BD28Xhsl2gs7o%3D (Pubitemid 43290920)
6. EM Lewiecki PD Miller MR McClung SB Cohen MA Bolognese Y Liu A Wang S Siddhanti LA Fitzpatrick AMG 162 Bone Loss Study Group 2007 Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD J Bone Miner Res 22 1832 1841 17708711 10.1359/jbmr.070809 1:CAS:528:DC%2BD2sXhsVyjtrjF (Pubitemid 351229299)
7. PD Miller MA Bolognese EM Lewiecki MR McClung B Ding M Austin Y Liu J San Martin AMG 162 Bone Loss Study Group 2008 Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial Bone 43 222 229 18539106 10.1016/j.bone.2008.04.007 1:CAS:528:DC%2BD1cXosVOitrk%3D
8. SR Cummings J San Martin MR McClung ES Siris R Eastell IR Reid P Delmas HB Zoog M Austin A Wang S Kutilek S Adami J Zanchetta C Libanati S Siddhanti C Christiansen FREEDOM Trial 2009 Denosumab for prevention of fractures in postmenopausal women with osteoporosis N Engl J Med 361 756 765 19671655 10.1056/NEJMoa0809493 1:CAS:528:DC%2BD1MXhtVWls7nF
9. H Orimo Y Sugioka M Fukunaga Y Muto T Hotokebuchi I Gorai T Nakamura K Kushida H Tanaka T Ikai Y Oh-hashi The Committee of the Japanese Society for Bone and Mineral Research for Development of Diagnostic Criteria of Osteoporosis 1998 Diagnostic criteria of primary osteoporosis J Bone Miner Metab 16 139 150 10.1007/s007740050038 (Pubitemid 28411037)
10. H Orimo Y Hayashi M Fukunaga T Sone S Fujiwara M Shiraki K Kushida S Miyamoto S Soen J Nishimura Y Oh-hashi T Hosoi I Gorai H Tanaka T Igai H Kishimoto The Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research 2001 Diagnostic criteria for primary osteoporosis: year 2000 revision J Bone Miner Metab 19 331 337 11685647 10.1007/s007740170001 1:STN:280:DC%2BD3MngvFGntw%3D%3D (Pubitemid 33041725)
11. HK Genant CY Wu C Van Kuijk MC Nevitt 1993 Vertebral fracture assessment using a semiquantitative technique J Bone Miner Res 8 1137 1148 8237484 10.1002/jbmr.5650080915 1:STN:280:DyaK2c%2FlsFyhuw%3D%3D (Pubitemid 23261108)
12. E Seeman PD Delmas DA Hanley D Sellmeyer AM Cheung E Shane A Kearns T Thomas SK Boyd S Boutroy C Bogado S Majumdar M Fan C Libanati J Zanchetta 2010 Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate J Bone Miner Res 25 8 1886 1894 20222106 10.1002/jbmr.81